Clinical Trial Update: Pharmacokinetics/Pharmacodynamics of Albiglutide [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic/pharmacodynamic data for albiglutide in type 2 diabetes patients are reported. The results describe exposure-response characteristics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-05-23